6:42 PM
 | 
Jun 14, 2013
 |  BC Extra  |  Financial News

Mast Therapeutics raises $25 million in follow-on

Mast Therapeutics Inc. (NYSE-M:MSTX) raised $25 million through the sale of 50 million units at $0.50 in a follow-on underwritten by Piper Jaffray and...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >